WORLD FIRST ETHICAL SKIN TESTING
Webinar Overview
CTISKIN™ by CTIBIOTECH™ has developed the world's first ethical newborn and infant baby skin model for cosmetics and drug testing: CTIBABYSKIN® kit. This innovative model uses umbilical cord explants cultivated in proprietary media to create a multilayered, cornified, and differentiated epidermis on a dermis rich in fibroblasts. The model has been validated through irritation tests using sodium dodecyl sulfate (SDS), demonstrating significant increases in interleukin-1 alpha production and decreases in cell viability. This ethical and highly sensitive baby skin model is suitable for industrial development and hospital diagnostics, providing a relevant testing system for products designed for babies and children.
Key Points
- Ethical Baby Skin Model Development
- Model Validation
- Irritation Testing with SDS
- Advantages of the Model
- Future Research
- NEW : CTIBabyskin kit
Our Speaker
Pauline PAYEN has a professional degree in tissue and cell culture and molecular biology. she has been a project manager at CTIBIOTECHTM for over 5 years. Amongst other projects, Pauline was responsible for the development of the BabySkin kit, a reference model for dermatocosmetic research worldwide. She is an expert in cell culture and efficacy and safety testing of skin products.
Nelly Dubrulle will be joining also along with Pauline, With a European Master's degree in Molecular Imaging, Nelly Dubrulle has worked for over 15 years in the life sciences sector, and for almost 10 years in business development for biotech start-ups. Currently International Business Developer at CTIBiotech, she is contributing to the company's international expansion.
CTISKIN™ by CTIBIOTECH™ develops innovative solutions to perform preclinical safety and efficacy evaluation of active ingredients, dermatocosmetics, personal care and hair care products, therapeutic candidates, cell therapies, aesthetic devices, and medical devices.